Genocea Provides First Quarter 2020 Corporate Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- Nio stock jumps after Goldman Sachs upgrade to buy
- Wall Street posts weekly gains with earnings, inflation data on tap
Genocea Biosciences (GNCA) Misses Q1 EPS by 11c
April 30, 2020 7:11 AM EDTGenocea Biosciences (NASDAQ: GNCA) reported Q1 EPS of ($0.46), $0.11 worse than the analyst estimate of ($0.35).
Genocea expects that its existing cash and cash equivalents are sufficient to support its operations into the first quarter of 2021.
For earnings history and earnings-related data on Genocea Biosciences (GNCA) click here.
... More


